Physiology, Pathophysiology and Pharmacology of Calcium Channels

A special issue of Membranes (ISSN 2077-0375). This special issue belongs to the section "Biological Membrane Composition and Structures".

Deadline for manuscript submissions: closed (20 May 2022) | Viewed by 13873

Special Issue Editor


E-Mail Website
Guest Editor
Department of Pathophysiology, Oita University School of Medicine, 879-5593 Oita, Japan
Interests: ion channels; ion transporters; electrophysiology; electropharmacology; electrocardiogram; arrhythmias; cellular signals; calcium signals; protein kinases

Special Issue Information

Dear Colleagues,

Calcium ions (Ca2+) affect nearly all aspects of cellular function. Thus, Ca2+ is a universal intracellular messenger that participates in numerous biological processes, including muscle contraction, excitation conduction, gene expression, cell growth, and cell death. This incredible versatility necessitates the tight regulation of intracellular Ca2+ concentration ([Ca2+]i) to ensure coordination among the multiple processes involving Ca2+ that underlie normal cell functioning. Underlying the physiological function and effectiveness of Ca2+ is the 20,000-fold gradient maintained by cells between their intracellular (∼100 nM free) and extracellular (mM) concentrations. Disrupted regulation of [Ca2+]i often leads to cell dysfunction, such as occurs in life-threatening diseases. Ca2+ influx across the plasma membrane occurs in multiple ways, including a phase of Ca2+ influx via calcium channels. The role of voltage-gated Ca2+ channels has long been extensively studied in physiological and pathophysiological conditions. Furthermore, both molecular genetic and pharmacological approaches have revealed the existence of functional Ca2+ channels in a variety of excitable and non-excitable cells. In this context, Ca2+ entry has long been recognized to be important to the function of excitable cells and the subsequent discovery of voltage-activated calcium conductances in these cells. Historically, these observations were rapidly followed by the identification of multiple subtypes of calcium conductance in different tissues. These were initially termed low- and high-voltage activated currents, but were then further subdivided into L-, N-, P/Q-, R-, and T-type calcium currents on the basis of pharmacology, voltage-dependent and kinetic properties, and single channel conductance. Purification of the Ca2+ channel allowed for the molecular identification of the pore-forming a and auxiliary α2/δ, β, and ϒ subunits present in these calcium channel complexes. These advances then led to the cloning of the different subunits, which permitted molecular characterization, to match the cloned channels with a physiological function. Studies with knockout/overexpression in mutant mice then allowed for further investigation of physiological and pathophysiological roles of these channels. In terms of clinical pharmacology, L-type channels are targets for the widely used antihypertensive 1,4-dihydropyridines and other calcium channel blockers, N-type channels are a drug target in pain, and α2/δ is the therapeutic target of the drugs used in neuropathic pain and as anticonvulsants. Recent studies have allowed for a deeper understanding of Ca2+ permeation through the channel pore and the structure of both the pore-forming and auxiliary subunits. Voltage-gated calcium channels are subject to multiple pathways of modulation by G-protein and second messenger regulation. Furthermore, their trafficking pathways, subcellular localization, and functional specificity are the subjects of active investigation. Furthermore, investigation of transcriptional, post-transcriptional, and translational modulation of Ca2+ channels has revealed multiple modulatory signals of Ca2+ channels in a wide variety of cells. This Special Issue focuses on recent research that elucidates cellular and molecular mechanisms for Ca2+ channel regulation and suggests new implications for calcium channel function and dysfunction in excitable and non-excitable cells, possibly related to ion-channel-mediated diseases or pathophysiology.

Prof. Dr. Katsushige Ono
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Membranes is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • calcium channels
  • calcium homeostasis
  • calcium signaling
  • calcium-dependent remodeling of cells
  • membrane potentials
  • intracellular calcium

Published Papers (5 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

13 pages, 3956 KiB  
Article
Diindolylmethane Derivatives: New Selective Blockers for T-Type Calcium Channels
by Dan Wang, Pratik Neupane, Lotten Ragnarsson, Robert J. Capon and Richard J. Lewis
Membranes 2022, 12(8), 749; https://doi.org/10.3390/membranes12080749 - 30 Jul 2022
Cited by 3 | Viewed by 1645
Abstract
The natural product indole-3-carbinol (I3C) and its major digestive product 3,3′-diindolylmethane (DIM) have shown clinical promise in multiple forms of cancer including breast cancer. In this study, we explored the calcium channel activity of DIM, its synthetic derivative 3,3′-Diindolylmethanone (DIM-one) and related I3C [...] Read more.
The natural product indole-3-carbinol (I3C) and its major digestive product 3,3′-diindolylmethane (DIM) have shown clinical promise in multiple forms of cancer including breast cancer. In this study, we explored the calcium channel activity of DIM, its synthetic derivative 3,3′-Diindolylmethanone (DIM-one) and related I3C and DIM-one analogs. For the first time, DIM, DIM-one and analog IX were identified as selective blockers for T-type CaV3.3 (IC50s DIM 2.09 µM; DIM-one 9.07 µM) while compound IX inhibited both CaV3.2 (6.68 µM) and CaV3.3 (IC50 = 3.05 µM) using a FLIPR cell-based assay to measure inhibition of T-type calcium channel window current. Further characterization of DIM by electrophysiology revealed it inhibited inward Ca2+ current through CaV3.1 (IC50 = 8.32 µM) and CaV3.3 (IC50 = 9.63 µM), while IX partially blocked CaV3.2 and CaV3.3 inward Ca2+ current. In contrast, DIM-one preferentially blocked CaV3.1 inward Ca2+ current (IC50 = 1.53 µM). The anti-proliferative activities of these compounds revealed that oxidation of the methylene group of DIM shifted the selectivity of DIMs from breast cancer cell line MCF-7 to colon cancer cell line HT-29. Full article
(This article belongs to the Special Issue Physiology, Pathophysiology and Pharmacology of Calcium Channels)
Show Figures

Figure 1

14 pages, 1728 KiB  
Communication
HIV-Induced Hyperactivity of Striatal Neurons Is Associated with Dysfunction of Voltage-Gated Calcium and Potassium Channels at Middle Age
by Christina E. Khodr, Lihua Chen, Lena Al-Harthi and Xiu-Ti Hu
Membranes 2022, 12(8), 737; https://doi.org/10.3390/membranes12080737 - 28 Jul 2022
Cited by 3 | Viewed by 1486
Abstract
Despite combination antiretroviral therapy, HIV-associated neurocognitive disorders (HAND) occur in ~50% of people living with HIV (PLWH), which are associated with dysfunction of the corticostriatal pathway. The mechanism by which HIV alters the neuronal activity in the striatum is unknown. The goal of [...] Read more.
Despite combination antiretroviral therapy, HIV-associated neurocognitive disorders (HAND) occur in ~50% of people living with HIV (PLWH), which are associated with dysfunction of the corticostriatal pathway. The mechanism by which HIV alters the neuronal activity in the striatum is unknown. The goal of this study is to reveal the dysfunction of striatal neurons in the context of neuroHIV during aging. Using patch-clamping electrophysiology, we evaluated the functional activity of medium spiny neurons (MSNs), including firing, Ca2+ spikes mediated by voltage-gated Ca2+ channels (VGCCs), and K+ channel-mediated membrane excitability, in brain slices containing the dorsal striatum (a.k.a. the caudate-putamen) from 12-month-old (12mo) HIV-1 transgenic (HIV-1 Tg) rats. We also assessed the protein expression of voltage-gated Cav1.2/Cav1.3 L-type Ca2+ channels (L-channels), NMDA receptors (NMDAR, NR2B subunit), and GABAA receptors (GABAARs, β2,3 subunit) in the striatum. We found that MSNs had significantly increased firing in 12mo HIV-1 Tg rats compared to age-matched non-Tg control rats. Unexpectedly, Ca2+ spikes were significantly reduced, while Kv channel activity was increased, in MSNs of HIV-1 Tg rats compared to non-Tg ones. The reduced Ca2+ spikes were associated with an abnormally increased expression of a shorter, less functional Cav1.2 L-channel form, while there was no significant change in the expression of NR2Bs or GABAARs. Collectively, the present study initially reveals neuroHIV-induced dysfunction of striatal MSNs in 12mo-old (middle) rats, which is uncoupled from VGCC upregulation and reduced Kv activity (that we previously identified in younger HIV-1 Tg rats). Notably, such striatal dysfunction is also associated with HIV-induced hyperactivity/neurotoxicity of glutamatergic pyramidal neurons in the medial prefrontal cortex (mPFC) that send excitatory input to the striatum (demonstrated in our previous studies). Whether such MSN dysfunction is mediated by alterations in the functional activity instead of the expression of NR2b/GABAAR (or other subtypes) requires further investigation. Full article
(This article belongs to the Special Issue Physiology, Pathophysiology and Pharmacology of Calcium Channels)
Show Figures

Figure 1

17 pages, 4194 KiB  
Article
Protein Kinase C Regulates Expression and Function of the Cav3.2 T-Type Ca2+ Channel during Maturation of Neonatal Rat Cardiomyocyte
by Yan Wang, Masaki Morishima and Katsushige Ono
Membranes 2022, 12(7), 686; https://doi.org/10.3390/membranes12070686 - 2 Jul 2022
Cited by 3 | Viewed by 1469
Abstract
Two distinct isoforms of the T-type Ca2+ channel, Cav3.1 and Cav3.2, play a pivotal role in the generation of pacemaker potentials in nodal cells in the heart, although the isoform switches from Cav3.2 to Cav3.1 during the early neonatal period with an [...] Read more.
Two distinct isoforms of the T-type Ca2+ channel, Cav3.1 and Cav3.2, play a pivotal role in the generation of pacemaker potentials in nodal cells in the heart, although the isoform switches from Cav3.2 to Cav3.1 during the early neonatal period with an unknown mechanism. The present study was designed to investigate the molecular system of the parts that are responsible for the changes of T-type Ca2+ channel isoforms in neonatal cardiomyocytes using the whole-cell patch-clamp technique and mRNA quantification. The present study demonstrates that PKC activation accelerates the Ni2+-sensitive beating rate and upregulates the Ni2+-sensitive T-type Ca2+ channel current in neonatal cardiomyocytes as a long-term effect, whereas PKC inhibition delays the Ni2+-sensitive beating rate and downregulates the Ni2+-sensitive T-type Ca2+ channel current. Because the Ni2+-sensitive T-type Ca2+ channel current is largely composed of the Cav3.2-T-type Ca2+ channel, it is accordingly assumed that PKC activity plays a crucial role in the maintenance of the Cav3.2 channel. The expression of Cav3.2 mRNA was highly positively correlated with PKC activity. The expression of a transcription factor Nkx2.5 mRNA, possibly corresponding to the Cav3.2 channel gene, was decreased by an inhibition of PKCβII. These results suggest that PKC activation, presumably by PKCβII, is responsible for the upregulation of CaV3.2 T-type Ca2+ channel expression that interacts with a cardiac-specific transcription factor, Nkx2.5, in neonatal cardiomyocytes. Full article
(This article belongs to the Special Issue Physiology, Pathophysiology and Pharmacology of Calcium Channels)
Show Figures

Figure 1

9 pages, 1497 KiB  
Article
L-Type Calcium Channel: Predicting Pathogenic/Likely Pathogenic Status for Variants of Uncertain Clinical Significance
by Svetlana I. Tarnovskaya, Anna A. Kostareva and Boris S. Zhorov
Membranes 2021, 11(8), 599; https://doi.org/10.3390/membranes11080599 - 7 Aug 2021
Cited by 5 | Viewed by 2479
Abstract
(1) Background: Defects in gene CACNA1C, which encodes the pore-forming subunit of the human Cav1.2 channel (hCav1.2), are associated with cardiac disorders such as atrial fibrillation, long QT syndrome, conduction disorders, cardiomyopathies, and congenital heart defects. Clinical manifestations are known only for 12% [...] Read more.
(1) Background: Defects in gene CACNA1C, which encodes the pore-forming subunit of the human Cav1.2 channel (hCav1.2), are associated with cardiac disorders such as atrial fibrillation, long QT syndrome, conduction disorders, cardiomyopathies, and congenital heart defects. Clinical manifestations are known only for 12% of CACNA1C missense variants, which are listed in public databases. Bioinformatics approaches can be used to predict the pathogenic/likely pathogenic status for variants of uncertain clinical significance. Choosing a bioinformatics tool and pathogenicity threshold that are optimal for specific protein families increases the reliability of such predictions. (2) Methods and Results: We used databases ClinVar, Humsavar, gnomAD, and Ensembl to compose a dataset of pathogenic/likely pathogenic and benign variants of hCav1.2 and its 20 paralogues: voltage-gated sodium and calcium channels. We further tested the performance of sixteen in silico tools in predicting pathogenic variants. ClinPred demonstrated the best performance, followed by REVEL and MCap. In the subset of 309 uncharacterized variants of hCav1.2, ClinPred predicted the pathogenicity for 188 variants. Among these, 36 variants were also categorized as pathogenic/likely pathogenic in at least one paralogue of hCav1.2. (3) Conclusions: The bioinformatics tool ClinPred and the paralogue annotation method consensually predicted the pathogenic/likely pathogenic status for 36 uncharacterized variants of hCav1.2. An analogous approach can be used to classify missense variants of other calcium channels and novel variants of hCav1.2. Full article
(This article belongs to the Special Issue Physiology, Pathophysiology and Pharmacology of Calcium Channels)
Show Figures

Figure 1

Review

Jump to: Research

15 pages, 950 KiB  
Review
Regulation of GABAA Receptors Induced by the Activation of L-Type Voltage-Gated Calcium Channels
by María Clara Gravielle
Membranes 2021, 11(7), 486; https://doi.org/10.3390/membranes11070486 - 29 Jun 2021
Cited by 8 | Viewed by 5389
Abstract
GABAA receptors are pentameric ion channels that mediate most synaptic and tonic extrasynaptic inhibitory transmissions in the central nervous system. There are multiple GABAA receptor subtypes constructed from 19 different subunits in mammals that exhibit different regional and subcellular distributions and [...] Read more.
GABAA receptors are pentameric ion channels that mediate most synaptic and tonic extrasynaptic inhibitory transmissions in the central nervous system. There are multiple GABAA receptor subtypes constructed from 19 different subunits in mammals that exhibit different regional and subcellular distributions and distinct pharmacological properties. Dysfunctional alterations of GABAA receptors are associated with various neuropsychiatric disorders. Short- and long-term plastic changes in GABAA receptors can be induced by the activation of different intracellular signaling pathways that are triggered, under physiological and pathological conditions, by calcium entering through voltage-gated calcium channels. This review discusses several mechanisms of regulation of GABAA receptor function that result from the activation of L-type voltage gated calcium channels. Calcium influx via these channels activates different signaling cascades that lead to changes in GABAA receptor transcription, phosphorylation, trafficking, and synaptic clustering, thus regulating the inhibitory synaptic strength. These plastic mechanisms regulate the interplay of synaptic excitation and inhibition that is crucial for the normal function of neuronal circuits. Full article
(This article belongs to the Special Issue Physiology, Pathophysiology and Pharmacology of Calcium Channels)
Show Figures

Figure 1

Back to TopTop